Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Satellos Bioscience Inc. MSLE

Full chart Compare
Set alert

Price alert · MSLE

All alert types
6.37 USD -0.03 (-0.47%)

At closeNov 3, 2026, 4:00 PM EST

6.37 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

6.37 Day range 6.46
5.30 52-week range 13.40
YTD
+8.33%
1 year
-2.00%

Financial health

Altman Z-Score

-1.72 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -0.3×
FY 2016: -2.0×FY 2017: -3.7×FY 2018: -2.0×FY 2019: -2.4×FY 2020: -8.4×FY 2021: -1.5×FY 2022: -2.5×FY 2023: -5.8×FY 2024: -4.7×FY 2025: -0.3×
FY 2016 5y median -2.5× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 1.4×FY 2017: 2.8×FY 2018: -5.5×FY 2019: 6.9×FY 2020: -72.5×FY 2021: 2.2×FY 2022: 8.5×FY 2023: 1.7×FY 2024: 2.1×FY 2025: 0.3×
FY 2016 5y median 2.1× FY 2025
P/FCF -0.4×
FY 2016: -2.5×FY 2017: 0.0×FY 2018: -3.1×FY 2019: -2.0×FY 2020: -8.0×FY 2021: -4.5×FY 2022: -6.7×FY 2023: -4.7×FY 2024: -5.6×FY 2025: -0.4×
FY 2016 5y median -4.7× FY 2025
EV/EBITDA 0.0×
FY 2016: -0.8×FY 2017: -1.4×FY 2018: -1.5×FY 2019: -1.6×FY 2020: -8.5×FY 2021: -3.0×FY 2022: -3.3×FY 2023: -3.8×FY 2024: -2.9×FY 2025: 0.0×
FY 2016 5y median -3.0× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -274.1%
FY 2016: -40.2%FY 2017: 0.0%FY 2018: -32.5%FY 2019: -49.2%FY 2020: -12.5%FY 2021: -22.0%FY 2022: -15.0%FY 2023: -21.4%FY 2024: -17.9%FY 2025: -274.1%
FY 2016 5y median -21.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -89.5%
FY 2016: -64.4%FY 2017: -113.8%FY 2018: 272.6%FY 2019: -293.4%FY 2020: 856.7%FY 2021: -188.6%FY 2022: -339.5%FY 2023: -29.4%FY 2024: -41.4%FY 2025: -89.5%
FY 2016 5y median -89.5% FY 2025
ROIC -95.2%
FY 2016: -53.2%FY 2017: -135.5%FY 2018: 352.6%FY 2019: -293.7%FY 2020: -304.2%FY 2021: -80.9%FY 2022: -252.6%FY 2023: -28.7%FY 2024: -41.0%FY 2025: -95.2%
FY 2016 5y median -80.9% FY 2025
ROA -78.0%
FY 2016: -60.8%FY 2017: -90.0%FY 2018: -955.6%FY 2019: -132.0%FY 2020: -139.4%FY 2021: -157.1%FY 2022: -184.5%FY 2023: -27.0%FY 2024: -38.5%FY 2025: -78.0%
FY 2016 5y median -78.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -36.6%
FY 2016: 43.8%FY 2017: -20.5%FY 2018: -46.8%FY 2019: -3.2%FY 2020: -22.4%FY 2021: -139.7%FY 2022: -26.8%FY 2023: -38.3%FY 2024: -66.2%FY 2025: -36.6%
FY 2016 FY 2025
EPS (diluted) -844.4%
FY 2016: -1.0%FY 2017: 49.6%FY 2018: -97.5%FY 2019: 19.1%FY 2020: 72.6%FY 2021: -462.6%FY 2022: 36.7%FY 2023: 57.2%FY 2024: -32.5%FY 2025: -844.4%
FY 2016 FY 2025
Free Cash Flow -35.6%
FY 2016: 56.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -108.7%FY 2020: 27.8%FY 2021: -137.6%FY 2022: -7.8%FY 2023: -238.6%FY 2024: -20.6%FY 2025: -35.6%
FY 2016 FY 2025

Financial Health

Current Ratio 7.8×
FY 2016: 17.5×FY 2017: 4.8×FY 2018: 0.2×FY 2019: 1.8×FY 2020: 5.1×FY 2021: 2.6×FY 2022: 0.8×FY 2023: 11.1×FY 2024: 14.2×FY 2025: 7.8×
FY 2016 5y median 7.8× FY 2025
Quick Ratio 7.8×
FY 2016: 17.5×FY 2017: 4.8×FY 2018: 0.2×FY 2019: 1.8×FY 2020: 5.1×FY 2021: 2.6×FY 2022: 0.8×FY 2023: 11.1×FY 2024: 14.2×FY 2025: 7.8×
FY 2016 5y median 7.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -5.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 2.0×FY 2017: 0.8×FY 2018: 0.0×FY 2019: 0.4×FY 2020: -0.2×FY 2021: 0.8×FY 2022: 0.2×FY 2023: 1.9×FY 2024: 2.1×FY 2025: 0.4×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -5557×FY 2021: -8.6×FY 2022: 0.0×FY 2023: -87.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31